title: Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States.
abstract: BACKGROUND
  Financial ties between health professionals and industry may unduly influence professional judgments and some researchers have suggested that widening disease definitions may be one driver of over-diagnosis, bringing potentially unnecessary labeling and harm. We aimed to identify guidelines in which disease definitions were changed, to assess whether any proposed changes would increase the numbers of individuals considered to have the disease, whether potential harms of expanding disease definitions were investigated, and the extent of members' industry ties.
  
  
  RESULTS
  We undertook a cross-sectional study of the most recent publication between 2000 and 2013 from national and international guideline panels making decisions about definitions or diagnostic criteria for common conditions in the United States. We assessed whether proposed changes widened or narrowed disease definitions, rationales offered, mention of potential harms of those changes, and the nature and extent of disclosed ties between members and pharmaceutical or device companies. Of 16 publications on 14 common conditions, ten proposed changes widening and one narrowing definitions. For five, impact was unclear. Widening fell into three categories: creating "pre-disease"; lowering diagnostic thresholds; and proposing earlier or different diagnostic methods. Rationales included standardising diagnostic criteria and new evidence about risks for people previously considered to not have the disease. No publication included rigorous assessment of potential harms of proposed changes. Among 14 panels with disclosures, the average proportion of members with industry ties was 75%. Twelve were chaired by people with ties. For members with ties, the median number of companies to which they had ties was seven. Companies with ties to the highest proportions of members were active in the relevant therapeutic area. Limitations arise from reliance on only disclosed ties, and exclusion of conditions too broad to enable analysis of single panel publications.
  
  
  CONCLUSIONS
  For the common conditions studied, a majority of panels proposed changes to disease definitions that increased the number of individuals considered to have the disease, none reported rigorous assessment of potential harms of that widening, and most had a majority of members disclosing financial ties to pharmaceutical companies. Please see later in the article for the Editors' Summary.
authors: Bond University, Robina, Australia. raymoynihan@bond.edu.au
authors: Raymond N
authors: RN
authors: Moynihan
authors: Georga P E
authors: GP
authors: Cooke
authors: Jenny A
authors: JA
authors: Doust
authors: Lisa
authors: L
authors: Bero
authors: Suzanne
authors: S
authors: Hill
authors: Paul P
authors: PP
authors: Glasziou
mesh_terms: D003430:Cross-Sectional Studies; D004194:Disease; D006801:Humans; D017410:Practice Guidelines as Topic; D014481:United States
references: PLoS One. 2011;6(10):e25153
references: 22039406
references: CMAJ. 2012 Apr 17;184(7):755-62
references: 22392937
references: JAMA. 2003 Jan 22-29;289(4):454-65
references: 12533125
references: Dtsch Arztebl Int. 2010 Apr;107(16):279-85
references: 20467553
references: Arch Intern Med. 2012 Nov 26;172(21):1628-33
references: 23089902
references: Endocr Pract. 2012 Mar-Apr;18 Suppl 1:1-78
references: 22522068
references: Eff Clin Pract. 1999 Mar-Apr;2(2):76-85
references: 10538480
references: Arch Intern Med. 2012 Aug 13;172(15):1123-4
references: 22733387
references: JAMA. 2002 Feb 6;287(5):612-7
references: 11829700
references: Cochrane Database Syst Rev. 2012 Dec 12;12:MR000033
references: 23235689
references: Am J Respir Crit Care Med. 2009 Jul 1;180(1):59-99
references: 19535666
references: Arthritis Rheum. 2010 Sep;62(9):2569-81
references: 20872595
references: Alzheimers Dement. 2011 May;7(3):263-9
references: 21514250
references: CMAJ. 2008 Nov 18;179(11):1121-31
references: 19015563
references: Am J Gastroenterol. 2006 Aug;101(8):1900-20; quiz 1943
references: 16928254
references: BMJ. 2011 Jun 24;342:d3621
references: 21705406
references: Diabetes Care. 2009 Jul;32(7):1327-34
references: 19502545
references: PLoS Med. 2012;9(3):e1001190
references: 22427747
references: Alzheimers Dement. 2011 May;7(3):270-9
references: 21514249
references: Circulation. 2012 Oct 16;126(16):2020-35
references: 22923432
references: Am J Public Health. 2011 Mar;101(3):399-404
references: 21233426
references: Ann Neurol. 2011 Feb;69(2):292-302
references: 21387374
references: BMJ. 2012 May 28;344:e3502
references: 22645185
references: J Contin Educ Nurs. 2008 Mar;39(3):112-8
references: 18386698
references: JAMA. 2006 Apr 26;295(16):1921-8
references: 16639051
references: BMJ. 2010 Mar 18;340:c1344
references: 20299696
references: Eur Respir J. 2002 Nov;20(5):1117-22
references: 12449163
references: Alzheimers Dement. 2011 May;7(3):280-92
references: 21514248